Novonix (NVNXF) Net Income towards Common Stockholders (2022 - 2024)

Novonix has reported Net Income towards Common Stockholders for 3 years, with the latest figure at -$28.7 million in Q4 2024.

• For the quarter ending Q4 2024, Net Income towards Common Stockholders fell 2.18% year-over-year to -$28.7 million; the trailing twelve-month figure through Dec 2025 stood at -$28.7 million (up 49.46% YoY), and the FY2025 full-year result was -$92.7 million, down 23.93% from the prior year.
• Net Income towards Common Stockholders for Q4 2024 stood at -$28.7 million, down from -$28.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$28.1 million in Q4 2023, with the low at -$31.0 million in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged -$29.3 million across 3 years, with a median of -$28.7 million in 2024.
• The largest YoY upside for Net Income towards Common Stockholders was 2.18% in 2024 against a maximum downside of 2.18% in 2024.
• Novonix's Net Income towards Common Stockholders stood at -$31.0 million in 2022, then increased by 9.5% to -$28.1 million in 2023, then declined by 2.18% to -$28.7 million in 2024.
• The last three Net Income towards Common Stockholders figures came in at -$28.7 million (Q4 2024), -$28.1 million (Q4 2023), and -$31.0 million (Q2 2022), per Business Quant data.